TREA

88517411 - I-MAB BIOPHARMA

Follow

Information

  • Trademark
  • 88517411
  • Serial Number
    88517411
  • Registration Number
    6629613
  • Filing Date
    July 16, 2019
    5 years ago
  • Registration Date
    January 25, 2022
    3 years ago
  • Transaction Date
    December 26, 2024
    3 months ago
  • Status Date
    January 25, 2022
    3 years ago
  • Published for Opposition Date
    September 07, 2021
    3 years ago
  • Location Date
    December 23, 2021
    3 years ago
  • First Use Anywhere Date
    April 13, 2020
    4 years ago
  • First Use In Commerce Date
    April 28, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    RINGLE, JIM
  • Attorney Docket Number
    54LW-301328
    Attorney Name
    Lisa Martens
    Law Office Assigned Location Code
    M20
  • Owners
Information
Mark Drawing Code
3
Mark Identification
I-MAB BIOPHARMA
Case File Statements
  • DM0000: The mark consists of a blue and green stylized ring having a blue and dark blue left portion and a green and light green right portion. To the right of the ring is the word "I-MAB" written in dark blue upper case letters with a fading green arched cross-stroke extending from the left leg of the letter "A" through its center and extending through the center of the letter "B". Below the word "I-MAB" is the word "BIOPHARMA" written in dark blue upper case letters. The color white appearing in the mark represents transparent space and is not a part of the mark.
  • GS0051: Monoclonal antibodies for use in disease testing; biological preparations for the treatment of cancer, tumor suppressing agents, anti-cancer preparations, and pharmaceutical preparations for the treatment of immune system related diseases and disorders, all comprising monoclonal antibodies
  • CC0000: The color(s) blue, dark blue, green, and light green is/are claimed as a feature of the mark.
  • DS0000: "BIOPHARMA"
  • GS0421: Biomedical research services; conducting early evaluations in the field of new pharmaceuticals; quality control of goods and services; product quality testing; pharmaceutical product evaluation; biological research; conducting clinical trials for others that feature or contain monoclonal antibodies; research and development services in the field of antibodies
Case File Event Statements
  • 7/19/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/23/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/24/2019 - 5 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 9/10/2019 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/12/2019 - 5 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/12/2019 - 5 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/12/2019 - 5 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 10/24/2019 - 5 years ago
    8 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/24/2019 - 5 years ago
    9 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 3/10/2020 - 5 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/10/2020 - 5 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/11/2020 - 5 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/9/2020 - 5 years ago
    13 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 4/9/2020 - 5 years ago
    14 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/9/2020 - 5 years ago
    15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 10/13/2020 - 4 years ago
    16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 4/13/2021 - 3 years ago
    17 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 6/3/2021 - 3 years ago
    18 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 6/3/2021 - 3 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/4/2021 - 3 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/1/2021 - 3 years ago
    22 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/1/2021 - 3 years ago
    23 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/1/2021 - 3 years ago
    21 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/29/2021 - 3 years ago
    25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/29/2021 - 3 years ago
    24 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/30/2021 - 3 years ago
    26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/2/2021 - 3 years ago
    27 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/2/2021 - 3 years ago
    28 - ASSIGNED TO LIE Type: ALIE
  • 8/18/2021 - 3 years ago
    29 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/7/2021 - 3 years ago
    30 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/7/2021 - 3 years ago
    31 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 11/2/2021 - 3 years ago
    32 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 11/12/2021 - 3 years ago
    33 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 11/12/2021 - 3 years ago
    35 - USE AMENDMENT FILED Type: IUAF
  • 12/13/2021 - 3 years ago
    34 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 12/21/2021 - 3 years ago
    36 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 12/23/2021 - 3 years ago
    37 - SU-EXAMINER'S AMENDMENT WRITTEN Type: SNEA
  • 12/23/2021 - 3 years ago
    38 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/23/2021 - 3 years ago
    39 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/23/2021 - 3 years ago
    40 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/23/2021 - 3 years ago
    41 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 12/24/2021 - 3 years ago
    42 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 1/25/2022 - 3 years ago
    43 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/17/2023 - a year ago
    44 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 12/25/2024 - 3 months ago
    45 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN